CELERA

CELERA is a human amnion chorion membrane (dHACM) allograft developed by MiMedx for the management of acute and chronic wounds. As a minimally manipulated, dehydrated placental tissue-based biologic, it is classified as a 361 HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products). The product retains the structural and functional characteristics of native placental membranes, providing a biocompatible extracellular matrix (ECM) that serves as a natural scaffold for cellular infiltration and tissue regeneration. CELERA supports the natural healing cascade by protecting the wound bed and aiding in the development of granulation tissue. It is compatible with adjunctive therapies such as negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT), and is intended for use by healthcare professionals in various clinical settings, including physician offices and hospitals.

Brand names

CELERA

Other names

dehydrated human amnion chorion membranedHACMhuman amnion chorion membrane allograft